Pricing Log in Create free account
Friday 6 November 2026 Export PBH’s income statement to Excel — free account

Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.

Revenue
+22.7%
EPS
−38.4%
Free cash flow
−38.2%
Total debt
+100.9%

Quarter to September 2026, against a year earlier

44.63 8.65 −16.23%
Market cap
$2.1B
P/E
13.7×
Fwd P/E
11.7×
Dividend yield
—
F-score
5/9
Altman Z
2.48
Beneish M
−2.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Prestige Consumer Healthcare Inc. (PBH) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Prestige Consumer Healthcare Inc. (PBH) trades at a P/S ratio of 1.8×. Over the past ten years it has ranged from 1.4× (March 2019) to 3.9× (March 2025); the current reading is higher than 10% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.1× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2026 2.6× (29.75%)
FY2025 3.8× 18.48%
FY2024 3.2× 14.39%
FY2023 2.8× 13.17%
FY2022 2.4× 4.35%
FY2021 2.3× 21.43%
FY2020 1.9× 23.36%
FY2019 1.6× (6.95%)
FY2018 1.7× (49.56%)
FY2017 3.3× (4.48%)

Quarterly newest first

Period P/S ratio Change
Sep 2026 1.9× (8.07%)
Jun 2026 2.0× (23.03%)
Mar 2026 2.6× (1.43%)
Dec 2025 2.7× (2.85%)
43 more quarters

Against its own ten years

Low 1.4× High 3.9×
Ten-year median 2.7×
Current reading's percentile 11

P/S ratio against peers

Company P/S ratio
HCM HUTCHMED (China) Limited Sponsored ADR compare n/m
PRGO Perrigo Company plc compare 0.5×
PBH Prestige Consumer Healthcare Inc. 1.8×
TRLV Trulieve Cannabis Corp. compare 2.0×
BCRX BioCryst Pharmaceuticals, Inc. compare 2.0×
ALVO Alvotech compare 4.6×
XERS Xeris Biopharma Holdings, Inc. compare 6.4×
AMLX Amylyx Pharmaceuticals, Inc. compare 35.4×
RGC Regencell Bioscience Holdings Limited compare —
Drug Manufacturers Specialty & Generic industry median 2.1×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on PBH